As of 2024-12-13, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -2.05. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 72.28 mil USD. AXDX's TTM EBITDA according to its financial statements is -35.25 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 22.0x | 21.2x |
| Forward P/E multiples | 21.3x - 22.9x | 21.8x |
| Fair Price | (31.55) - (32.51) | (31.84) |
| Upside | -2437.3% - -2508.2% | -2458.7% |
| Date | EV/EBITDA |
| 2024-12-10 | -2.11 |
| 2024-12-09 | -2.16 |
| 2024-12-06 | -2.21 |
| 2024-12-05 | -2.21 |
| 2024-12-04 | -2.30 |
| 2024-12-03 | -2.21 |
| 2024-12-02 | -2.26 |
| 2024-11-29 | -2.27 |
| 2024-11-27 | -2.23 |
| 2024-11-26 | -2.26 |
| 2024-11-25 | -2.26 |
| 2024-11-22 | -2.26 |
| 2024-11-21 | -2.28 |
| 2024-11-20 | -2.30 |
| 2024-11-19 | -2.33 |
| 2024-11-18 | -2.37 |
| 2024-11-15 | -2.41 |
| 2024-11-14 | -2.42 |
| 2024-11-13 | -2.43 |
| 2024-11-12 | -2.48 |
| 2024-11-11 | -2.45 |
| 2024-11-08 | -2.39 |
| 2024-11-07 | -2.49 |
| 2024-11-06 | -2.50 |
| 2024-11-05 | -2.52 |
| 2024-11-04 | -2.42 |
| 2024-11-01 | -2.46 |
| 2024-10-31 | -2.46 |
| 2024-10-30 | -2.43 |
| 2024-10-29 | -2.41 |
| 2024-10-28 | -2.43 |
| 2024-10-25 | -2.43 |
| 2024-10-24 | -2.35 |
| 2024-10-23 | -2.36 |
| 2024-10-22 | -2.41 |
| 2024-10-21 | -2.41 |
| 2024-10-18 | -2.38 |
| 2024-10-17 | -2.33 |
| 2024-10-16 | -2.44 |
| 2024-10-15 | -2.42 |
| 2024-10-14 | -2.31 |
| 2024-10-11 | -2.34 |
| 2024-10-10 | -2.40 |
| 2024-10-09 | -2.39 |
| 2024-10-08 | -2.46 |
| 2024-10-07 | -2.43 |
| 2024-10-04 | -2.48 |
| 2024-10-03 | -2.38 |
| 2024-10-02 | -2.40 |
| 2024-10-01 | -2.41 |